Suppr超能文献

先天免疫、自噬和成纤维细胞激活在肺纤维化发病机制中的作用。

Influences of innate immunity, autophagy, and fibroblast activation in the pathogenesis of lung fibrosis.

作者信息

O'Dwyer David N, Ashley Shanna L, Moore Bethany B

机构信息

Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan;

Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan; Graduate Program in Immunology, University of Michigan, Ann Arbor, Michigan; and.

出版信息

Am J Physiol Lung Cell Mol Physiol. 2016 Sep 1;311(3):L590-601. doi: 10.1152/ajplung.00221.2016. Epub 2016 Jul 29.

Abstract

Idiopathic pulmonary fibrosis (IPF) is a progressive interstitial lung disease characterized by accumulation of extracellular matrix (ECM) and impaired gas exchange. The pathobiological mechanisms that account for disease progression are poorly understood but likely involve alterations in innate inflammatory cells, epithelial cells, and fibroblasts. Thus we seek to review the most recent literature highlighting the complex roles of neutrophils and macrophages as both promoters of fibrosis and defenders against infection. With respect to epithelial cells and fibroblasts, we review the data suggesting that defective autophagy promotes the fibrogenic potential of both cell types and discuss new evidence related to matrix metalloproteinases, growth factors, and cellular metabolism in the form of lactic acid generation that may have consequences for promoting fibrogenesis. We discuss potential cross talk between innate and structural cell types and also highlight literature that may help explain the limitations of current IPF therapies.

摘要

特发性肺纤维化(IPF)是一种进行性间质性肺病,其特征是细胞外基质(ECM)积聚和气体交换受损。导致疾病进展的病理生物学机制尚不清楚,但可能涉及先天性炎症细胞、上皮细胞和成纤维细胞的改变。因此,我们试图回顾最新的文献,突出中性粒细胞和巨噬细胞作为纤维化促进者和抗感染防御者的复杂作用。关于上皮细胞和成纤维细胞,我们回顾了表明自噬缺陷促进这两种细胞类型纤维化潜能的数据,并讨论了与基质金属蛋白酶、生长因子以及以乳酸生成形式存在的细胞代谢相关的新证据,这些可能对促进纤维化产生影响。我们讨论了先天性细胞和结构细胞类型之间潜在的相互作用,还突出了可能有助于解释当前IPF治疗局限性的文献。

相似文献

1
Influences of innate immunity, autophagy, and fibroblast activation in the pathogenesis of lung fibrosis.
Am J Physiol Lung Cell Mol Physiol. 2016 Sep 1;311(3):L590-601. doi: 10.1152/ajplung.00221.2016. Epub 2016 Jul 29.
2
Alveolar epithelial disintegrity in pulmonary fibrosis.
Am J Physiol Lung Cell Mol Physiol. 2016 Aug 1;311(2):L185-91. doi: 10.1152/ajplung.00115.2016. Epub 2016 May 27.
5
Interventions for fertility preservation in women with cancer undergoing chemotherapy.
Cochrane Database Syst Rev. 2025 Jun 19;6:CD012891. doi: 10.1002/14651858.CD012891.pub2.
7
MHCIILYVE1CCR2 Interstitial Macrophages Promote Medial Fibrosis in Pulmonary Arterioles and Contribute to Pulmonary Hypertension.
Circ Res. 2025 Jun 20;137(1):46-66. doi: 10.1161/CIRCRESAHA.125.326173. Epub 2025 May 13.
8
RNA-sequencing reveals differential fibroblast responses to bleomycin and pneumonectomy.
Physiol Rep. 2024 Jul;12(13):e16148. doi: 10.14814/phy2.16148.
9
Electronic cigarettes for smoking cessation.
Cochrane Database Syst Rev. 2024 Jan 8;1(1):CD010216. doi: 10.1002/14651858.CD010216.pub8.
10
Electronic cigarettes for smoking cessation.
Cochrane Database Syst Rev. 2025 Jan 29;1(1):CD010216. doi: 10.1002/14651858.CD010216.pub9.

引用本文的文献

1
2
The Immune Microenvironment: New Therapeutic Implications in Organ Fibrosis.
Adv Sci (Weinh). 2025 Aug;12(30):e05067. doi: 10.1002/advs.202505067. Epub 2025 May 20.
3
Overexpression of STX11 alleviates pulmonary fibrosis by inhibiting fibroblast activation via the PI3K/AKT/mTOR pathway.
Signal Transduct Target Ther. 2024 Nov 11;9(1):306. doi: 10.1038/s41392-024-02011-y.
4
PTB Regulates Keloid Fibroblast Migration and Proliferation Through Autophagy.
Aesthetic Plast Surg. 2025 Feb;49(3):897-907. doi: 10.1007/s00266-024-04375-6. Epub 2024 Oct 14.
5
6
An emerging view on vascular fibrosis molecular mediators and relevant disorders: from bench to bed.
Front Cardiovasc Med. 2023 Dec 21;10:1273502. doi: 10.3389/fcvm.2023.1273502. eCollection 2023.
8
Arsenic exposure and lung fibrotic changes-evidence from a longitudinal cohort study and experimental models.
Front Immunol. 2023 Aug 22;14:1225348. doi: 10.3389/fimmu.2023.1225348. eCollection 2023.
9
Molecular Mechanisms and Risk Factors Related to the Pathogenesis of Peyronie's Disease.
Int J Mol Sci. 2023 Jun 14;24(12):10133. doi: 10.3390/ijms241210133.
10
Cytokine signaling converging on in ILD fibroblasts provokes aberrant epithelial differentiation signatures.
Front Immunol. 2023 May 17;14:1128239. doi: 10.3389/fimmu.2023.1128239. eCollection 2023.

本文引用的文献

1
Regulation of macroautophagy in amiodarone-induced pulmonary fibrosis.
J Pathol Clin Res. 2015 Jun 3;1(4):252-63. doi: 10.1002/cjp2.20. eCollection 2015 Oct.
2
Six-SOMAmer Index Relating to Immune, Protease and Angiogenic Functions Predicts Progression in IPF.
PLoS One. 2016 Aug 4;11(8):e0159878. doi: 10.1371/journal.pone.0159878. eCollection 2016.
3
Periostin regulates fibrocyte function to promote myofibroblast differentiation and lung fibrosis.
Mucosal Immunol. 2017 Mar;10(2):341-351. doi: 10.1038/mi.2016.61. Epub 2016 Jul 20.
4
Autophagy, Inflammation, and Immunity: A Troika Governing Cancer and Its Treatment.
Cell. 2016 Jul 14;166(2):288-298. doi: 10.1016/j.cell.2016.05.051.
5
Differential regulation of autophagy and mitophagy in pulmonary diseases.
Am J Physiol Lung Cell Mol Physiol. 2016 Aug 1;311(2):L433-52. doi: 10.1152/ajplung.00128.2016. Epub 2016 Jul 8.
6
The Lung Microbiome, Immunity, and the Pathogenesis of Chronic Lung Disease.
J Immunol. 2016 Jun 15;196(12):4839-47. doi: 10.4049/jimmunol.1600279.
9
Incidence and prevalence of idiopathic pulmonary fibrosis in US adults 18-64 years old.
Eur Respir J. 2016 Jul;48(1):179-86. doi: 10.1183/13993003.01653-2015. Epub 2016 Apr 28.
10
Autophagy: Friend or Foe in Lung Disease?
Ann Am Thorac Soc. 2016 Mar;13 Suppl 1(Suppl 1):S40-7. doi: 10.1513/AnnalsATS.201507-450MG.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验